Aldose reductase activation is a key component of myocardial response to ischemia
- 14 December 2001
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 16 (2), 1-22
- https://doi.org/10.1096/fj.01-0368fje
Abstract
Aldose reductase, a member of the aldo-keto reductase family, has been implicated in the development of vascular and neurological complications in diabetes. Despite recent studies from our laboratory demonstrating protection of ischemic hearts by an aldose reductase inhibitor, the presence and influence of aldose reductase in cardiac tissue remain unknown. Our goal in this study was to isolate and characterize the kinetic properties of cardiac aldose reductase, as well as to study the impact of flux via this enzyme on glucose metabolism and contractile function in hearts subjected to ischemia-reperfusion. Results demonstrate that ischemia increases myocardial aldose reductase activity and that these increases are, in part, due to activation by nitric oxide. The kinetic parameter of cardiac aldose reductase (Kcat) was significantly higher in ischemic tissues. Aldose reductase inhibition increased glycolysis and glucose oxidation. Aldose reductase inhibited hearts, when subjected to ischemia/reperfusion, exhibited less ischemic injury and was associated with lower lactate/pyruvate ratios (a measure of cytosolic NADH/NAD+), greater tissue content of adenosine triphosphate, and improved cardiac function. These findings indicate that aldose reductase is a component of ischemic injury and that pharmacological inhibitors of aldose reductase present a novel adjunctive approach for protecting ischemic hearts.Keywords
Funding Information
- American Heart Association (0040152N)
This publication has 41 references indexed in Scilit:
- Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.JCI Insight, 1997
- Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventionsCardiovascular Research, 1997
- Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitorCurrent Eye Research, 1997
- Cyclic GMP in the perfused rat heart Effect of ischaemia, anoxia and nitric oxide synthase inhibitorFEBS Letters, 1994
- Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damageDiabetes/Metabolism Research and Reviews, 1993
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsThe New England Journal of Medicine, 1987
- Role of aldose reductase in the development of diabetes-associated complicationsThe American Journal of Medicine, 1985
- Activation of aldose reductase from human tissuesDiabetes, 1985
- Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and TherapyDiabetes Care, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976